Beta
112753

PROTECTIVE EFFICACY OF COMMERCIAL NEW CASTLE DISEASE VACCINES AGAINST VIRULENT GENOTYPE VII NEWCASTLE DISEASE VIRUS

Article

Last updated: 04 Jan 2025